GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2201 - 2225** of **4050** in total

« First

‹ Prev

…

85

86

87

88

89

90

91

92

93

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	22	moderate	G49916XD	291
IgA	Patient 2	15	mild	G65889KE	291
IgA	Patient 2	24	mild	G00065MO	291
IgA	Patient 2	24	mild	G91237TK	291
IgM	Patient 2	15	mild	G53168IY	291
IgG	Patient 3	11	mild	G47362BJ	291
IgA	Patient 1	22	moderate	G00051MO	292
IgM	Patient 2	3	mild	G32473MI	292
IgG	Patient 3	4	mild	G80587NA	292
IgM	Patient 3	4	mild	G96557TJ	292
IgA	Patient 1	22	moderate	G32611KT	293
IgA	Patient 1	22	moderate	G61399NC	293
IgA	Patient 2	15	mild	G92823JK	293
IgA	Patient 3	-180	mild	G00065MO	293
IgA	Patient 3	-180	mild	G66937TJ	293
IgA	Patient 2	24	mild	G76615YG	294
IgA	Patient 3	-180	mild	G96557TJ	294
IgA	Patient 1	6	moderate	G82348BZ	295
IgM	Patient 1	22	moderate	G42666HT	295
IgM	Patient 2	15	mild	G60761LT	295
IgA	Patient 2	3	mild	G00048MO	295
IgA	Patient 2	3	mild	G11460AB	295
IgG	Patient 3	11	mild	G90562PB	295
IgG	Patient 4	12	mild	G14844CX	295
IgA	Patient 2	24	mild	G00068MO	296